Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.
Recruiting
N/A
Interventional Study
Pre-Eclampsia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 200 (estimated)
- Sponsor
- Saint Thomas Hospital, Panama · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pregnant women between 24 and 40 weeks of gestation.
Exclusion Criteria:
* Multiple gestation
* Maternal vasculitis
* Previous cesarean section (3 or more)
* Brain or eye tumors
* Neurological conditions
* Chronic renal disease
* Purpura
* Heart disease
Contacts